ATS 2019 Virtual Final Program

1010 Protein Digestion, but Not Amino Acid Absorption, Is Compromised During Feeding in Chronic Obstructive Pulmonary Disease/ A. McNew, N.E.P. Deutz, S.Y. Simbo, J.J. Thaden, G.A.M. ten have, M.P.K.J. Engelen, College Station, TX, p.A5730 1011 Barriers to COPD-Patients’ Starting Pulmonary Rehabilitation: A Comparison Between Telehealth and Standard Pulmonary Rehabilitation Referrals/ J. Polo, D. Madera, E. Boye-Codjoe, B. Guerrero, D. Tsang, R. Medina, A. Kozikowski, R. Pekmezaris, N. Hajizadeh, Manhasset, NY, p.A5731 1012 The Effect of Music on Walk Enjoyment and Symptoms in Adults with Chronic Lung Diseases/ A. Norweg, J.H. Whiteson, D. Veltri, J. Mejia, G. Sweeney, E.G. Collins, J.A. Krishnan, Y. Lu, F. Haas, New York, NY, p.A5732 1013 Impact of Pulmonary Rehabilitation on Sleep in COPD Patients as Measured by Actigraphy/ S.B. Thapamagar, K.E. Ellstrom, J.D. Anholm, N. Dandamudi, Redlands, CA, p.A5733 1014 Dyspnea and Functional Capacity Are Associated with Interventricular Septum Thickness in COPD Patients/ R.G. Mendes, A.D. Heubel, E.Z. Kabbach, A. Agnoleto, P.B. dos Santos, A. Borghi-Silva, A.C. Sentanin, V.A.P. Di-Lorenzo, M.G. Roscani, Sao Carlos, Brazil, p.A5734 1015 Home-Based Rehabilitation for COPD: A Qualitative Analysis of a Large Randomized Study/ B. Thomas, J.L. Ridgeway, P.J. Novotny, R. Benzo, Rochester, MN, p.A5735 1016 Is the 1-Minute Sit to Stand Test a Functional Capacity Test in Patients with Severe Chronic Obstructive Pulmonary Disease?/ S. Géphine, S. Bergeron, D. Saey, P. Mucci, F. Maltais, Quebec City, Canada, p.A5736 1017 Predictors of Pulmonary Rehabilitation Completion in the Chronic Obstructive Pulmonary Disease Population: National Audit Data from the United Kingdom/ P. Stone, M. Steiner, V. McMillan, C.M. Roberts, J.K. Quint, S.J. Singh, London, United Kingdom, p.A5737 1018 What Influences Referral to Pulmonary Rehabilitation from Primary Care: Analysis of National Audit Data/ P. Stone, N. Baxter, V. McMillan, C.M. Roberts, J.K. Quint, S.J. Singh, London, United Kingdom, p.A5738 1019 Hospitalized COPD Patients’ Perceptions of Pulmonary Rehabilitation: Barriers and Facilitators to Enrollment and Adherence/ K.A. Spitzer, M.S. Stefan, A. Drake, Q. Pack, T. Lagu, K. Mazor, V.M. Pinto-Plata, R.L. ZuWallack, P.K. Lindenauer, Springfield, MA, p.A5739 1020 Life-Time Pulmonary Rehabilitative Management of COPD Integrated into the Doctor’s Office Setting Update on the 17 th year of a Continuous Care Model/ B.L. Tiep, M. Barnett, R.R. Carter, R. Murray, Monrovia, CA, p.A5740 1021 The Effect of Endogenous Opioids on the Peripheral Modulation of Breathlessness in People with Moderate to Severe COPD/ M.P. Ekstrom, T. Hunt, S. Louw, D.J. Eckert, P. Allcroft, T. To, M. Krajnik, D.A. Mahler, D. Currow, Lund, Sweden, p.A5741 BASIC • TRANSLATIONAL POSTER DISCUSSION SESSION C107 GOING VIRAL TO REPAIR 2:15 p.m. - 4:15 p.m. KBHCCD Room D222-D224 (Level 2) Poster Viewing 2:15-3:00 Discussion 3:00-4:15 Chairing: S. Herold, MD, PhD, Giessen, Germany N.W. Lukacs, PhD, Ann Arbor, MI M.B. Hershenson, MD, Ann Arbor, MI 501 Enhanced Tissue Damage Following H1N1 Infection in Human Precision-Cut Lung Slices (PCLS)/ O. Danov, G. Martin, A. Greif, B. Bailly, P. Braubach, D.D. Jonigk, G. Warnecke, M. von Itzstein, K. Sewald, S. Wronski, A. Braun, Hannover, Germany, p.A5742 502 IL-1 Cytokines Are Critical Regulators of Matrix Protease Expression in the Respiratory Tract During Severe Influenza A Virus Infection/ D.F. Boyd, E.K. Allen, X.J. Guo, J.C. Crawford, P.G. Thomas, Memphis, TN, p.A5743 503 Age-Related Phagocytic Defect in Resident Muscle Macrophages Drives Decreased Capacity for Recovery from Influenza-Induced Muscle Atrophy/ C.E. Runyan, L.C. Welch, E. Lecuona, M. Shigemura, L. Amarelle, R. Aillon, K. Williams, S. Watanabe, A.C. McQuattie-Pimentel, G.S. Budinger, A. Misharin, J.I. Sznajder, Chicago, IL, p.A5744 504 BPIFA1 Regulates Neutrophilic Response of Influenza A Virus Infection/ S. Khanal, N. Niu, L.K. Sharma, S.D. Bermejo, W. Liu, L.E. Cohn, C.J. Britto-Leon, New Haven, CT, p.A5745 505 Death Ligands Are Upregulated in Influenza Pneumonia and Contribute to Depletion of the Resident Alveolar Macrophage Pool/ C. Malainou, C. Peteranderl, U. Matt, W. Seeger, S. Herold, Giessen, Germany, p.A5746 506 Alveolar Macrophage-Derived Extracellular Vesicles Protect Alveolar Epithelial Cells from Influenza Infection/ D. Schneider, D. Lyons, C. Wilke, L.R.K. Penke, A. Lauring, B.B. Moore, M. Peters-Golden, Ann Arbor, MI, p.A5747 507 Hypercapnia Increases Influenza A Virus Replication in Airway Epithelium Through a Sterol-Regulatory Element Binding Protein 2 (SREBP2)-Dependent Mechanism/ M. Casalino-Matsuda, F. Chen, A. Matsuda, P.H.S. Sporn, Chicago, IL, p.A5748 508 Transcriptional Profiling of Sorted Alveolar Epithelial and Macrophage Cells Reveals Distinct Early Cell Type Specific Response in Juvenile Mice Following Influenza A Virus Infection/ K. Anekalla, B. Coates, C. Koch, M. Turner, R. Verma, H. Abdala-Valencia, D.R. Winter, K.M. Ridge, Chicago, IL, p.A5749 509 Interstitial Heparan Sulfate Deposition in a Mouse Influenza Model of Lung Fibrosis/ S. Liao, Y. Yang, H.L. Twigg, R. Linhardt, E.P. Schmidt, Aurora, CO, p.A5750 510 Acutely Lethal Influenza Infection Truncates the Citric Acid Cycle in Murine Alveolar Type II Epithelial Cells/ L.M. Doolittle, L.E. Rosas, L.M. Joseph, P.S. Woods, I.C. Davis, Columbus, OH, p.A5751 ATS 2019 • Dallas, TX 306 TUESDAY • MAY 21